Hakutulokset - Wen‐Bin Ding
- Näytetään 1 - 2 yhteensä 2 tuloksesta
-
1
Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study Tekijä Zhi‐Cheng Jin, Bin‐Yan Zhong, Jian-Jia Chen, Hai‐Dong Zhu, Jun‐Hui Sun, Guowen Yin, Naijian Ge, Biao Luo, Wen‐Bin Ding, Wenhui Li, Li Chen, Yu-Qing Wang, Xiaoli Zhu, Yang Weizhu, H. Li, Gao‐Jun Teng
Julkaistu 2023Artigo -
2
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001) Tekijä Hai‐Dong Zhu, Hai-Liang Li, Mingsheng Huang, Yang Weizhu, Guowen Yin, Bin‐Yan Zhong, Jun‐Hui Sun, Zhi‐Cheng Jin, Jian-Jia Chen, Naijian Ge, Wen‐Bin Ding, Wenhui Li, Jinhua Huang, Wei Mu, Shanzhi Gu, Jiaping Li, Hui Zhao, Wen Shu-wei, Yanming Lei, Yusheng Song, Chunwang Yuan, Weidong Wang, Ming Huang, Wei Zhao, Jianbing Wu, Song Wang, Xu Zhu, Jianjun Han, Weixin Ren, Zaiming Lu, Wenge Xing, Yong Fan, Hailan Lin, Zishu Zhang, Guohui Xu, Wenhao Hu, Qiang Tu, Hongying Su, Chuansheng Zheng, Yong Chen, Xuya Zhao, Zhu-ting Fang, Qi Wang, Jinwei Zhao, Aibing Xu, Jian Xu, Qinghua Wu, Huanzhang Niu, Jian Wang, Feng Dai, Duiping Feng, Qingdong Li, Rong-Shu Shi, Jiarui Li, Guang Yang, Hai‐Bin Shi, Jiansong Ji, Yue Liu, Zheng Cai, Po Song Yang, Yang Zhao, Xiaoli Zhu, Ligong Lu, Gao‐Jun Teng
Julkaistu 2023Artigo
Työkalut:
Liittyvät aiheet
Combination therapy
Confidence interval
Gastroenterology
Hazard ratio
Hepatocellular carcinoma
Internal medicine
Medicine
Oncology
Propensity score matching
Adverse effect
Apatinib
Cancer
Chemotherapy
Clinical endpoint
Clinical trial
Environmental health
Overall survival
Population
Progression-free survival
Progressive disease
Proportional hazards model
Response Evaluation Criteria in Solid Tumors
Retrospective cohort study
Surgery